Source: https://www.nytimes.com/2020/04/30/technology/coronavirus-treatment-benevolentai-baricitinib.html
May 01, 2020 at 02:27AM
Specialists at the London start-up BenevolentAI helped identify the arthritis drug baricitinib, which is now part of a clinical trial.
No comments:
Post a Comment